Article Sidebar
Published:
May 13, 2016Keywords:
AIT allergic disease allergen-specific immunotherapy allergic rhinitis clinical efficacy SCIT SLIT subcutaneous immunotherapy sublingual immunotherapy
Article Details
Issue
Section
Articles
By submitting manuscripts to SAFP, authors of original articles are assigning copyright to the SA Academy of Family Practice/Primary Care. Copyright of review articles are assigned to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAFP for educational and research purposes without obtaining permission.
Main Article Content
Sublingual immunotherapy for the treatment of allergies
Abstract
The treatment of allergies often involves pharmacological therapy and recommendations by healthcare workers that the allergen should be avoided. Allergen-specific immunotherapy has emerged as an alternative to effectively decrease the immunoglobulin (Ig) E:IgG4 ratio. Two routes of administration are described, namely subcutaneous immunotherapy, which has always been considered to be the gold standard of treatment, and sublingual immunotherapy, which has recently been shown to have fewer systemic side-effects and improved compliance by patients.
Keywords: AIT, allergic disease, allergen-specific immunotherapy, allergic rhinitis, clinical efficacy, SCIT, SLIT, subcutaneous immunotherapy, sublingual immunotherapy
